Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Zoetis Share Holder Equity 2011-2025 | ZTS

Zoetis share holder equity from 2011 to 2025. Share holder equity can be defined as the sum of preferred and common equity items
  • Zoetis share holder equity for the quarter ending June 30, 2025 was $4.977B, a 0.34% increase year-over-year.
  • Zoetis share holder equity for 2024 was $4.77B, a 4.43% decline from 2023.
  • Zoetis share holder equity for 2023 was $4.991B, a 13.35% increase from 2022.
  • Zoetis share holder equity for 2022 was $4.403B, a 3.1% decline from 2021.
Zoetis Annual Share Holder Equity
(Millions of US $)
2024 $4,770
2023 $4,991
2022 $4,403
2021 $4,544
2020 $3,773
2019 $2,708
2018 $2,185
2017 $1,786
2016 $1,499
2015 $1,091
2014 $1,337
2013 $962
2012 $4,041
2011 $3,736
2010 $0
Zoetis Quarterly Share Holder Equity
(Millions of US $)
2025-06-30 $4,977
2025-03-31 $4,655
2024-12-31 $4,770
2024-09-30 $5,234
2024-06-30 $4,960
2024-03-31 $5,052
2023-12-31 $4,991
2023-09-30 $5,074
2023-06-30 $4,621
2023-03-31 $4,491
2022-12-31 $4,403
2022-09-30 $4,662
2022-06-30 $4,580
2022-03-31 $4,658
2021-12-31 $4,544
2021-09-30 $4,681
2021-06-30 $4,352
2021-03-31 $4,092
2020-12-31 $3,773
2020-09-30 $3,607
2020-06-30 $2,987
2020-03-31 $2,753
2019-12-31 $2,708
2019-09-30 $2,678
2019-06-30 $2,411
2019-03-31 $2,317
2018-12-31 $2,185
2018-09-30 $2,118
2018-06-30 $1,982
2018-03-31 $1,975
2017-12-31 $1,786
2017-09-30 $2,019
2017-06-30 $1,746
2017-03-31 $1,635
2016-12-31 $1,499
2016-09-30 $1,598
2016-06-30 $1,371
2016-03-31 $1,187
2015-12-31 $1,091
2015-09-30 $1,254
2015-06-30 $1,202
2015-03-31 $1,305
2014-12-31 $1,337
2014-09-30 $1,389
2014-06-30 $1,283
2014-03-31 $1,099
2013-12-31 $962
2013-09-30 $866
2013-06-30 $823
2013-03-31 $724
2012-12-31 $4,041
2012-09-30 $0
2012-06-30 $0
2012-03-31 $0
2011-12-31 $3,736
2010-12-31 $0
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $53.394B $9.256B
Zoetis Inc. is a leader in the animal health space with a focus on both livestock and companion animals in seven major product categories: vaccines, anti-infectives, parasiticides, dermatology, other pharmaceutical products, medicated feed additives and animal health diagnostics. Zoetis has a diversified business, which caters to eight core species ' cattle, swine, poultry, fish and sheep (collectively, livestock) and dogs, cats and horses (collectively, companion animals). It directly markets its products to veterinarians and livestock producers. The outstanding growth rate in the companion animal medicines, vaccines and diagnostics sector is being driven by economic development, related increases in disposable income and a rise in pet ownership and spending on pet care.Zoetis has been working on strengthening its product portfolio through acquisitions and deals.
Stock Name Country Market Cap PE Ratio
Chugai Pharmaceutical (CHGCY) Japan $85.303B 32.40
Takeda Pharmaceutical (TAK) Japan $45.311B 9.25
Daiichi Sankyo, - (DSNKY) Japan $41.164B 20.50
BeOne Medicines - (ONC) Switzerland $40.396B 214.16
Sandoz Group AG (SDZNY) Switzerland $30.312B 0.00
United Therapeutics (UTHR) United States $19.905B 17.52
Merck (MKKGY) Germany $18.217B 11.23
Shionogi (SGIOY) Japan $14.768B 13.56
Neurocrine Biosciences (NBIX) United States $14.374B 34.49
Summit Therapeutics (SMMT) United States $14.081B 0.00
IPSEN (IPSEY) France $12.599B 0.00
Madrigal Pharmaceuticals (MDGL) United States $11.695B 0.00
Ionis Pharmaceuticals (IONS) United States $11.312B 0.00
Orion OYJ (ORINY) Finland $9.625B 27.50
Eisai (ESAIY) $8.353B 0.00
Corcept Therapeutics (CORT) United States $7.968B 86.08
Stevanato Group S.p.A (STVN) Italy $6.862B 38.41
Grifols, S.A (GRFS) Spain $5.982B 0.00
Ono Pharmaceutical (OPHLF) Japan $5.204B 15.83
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $4.586B 0.00
NewAmsterdam Pharma (NAMS) Netherlands $4.130B 0.00
Crinetics Pharmaceuticals (CRNX) United States $3.931B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $3.621B 17.19
Centessa Pharmaceuticals (CNTA) United Kingdom $3.478B 0.00
Hypermarcas (HYPMY) Brazil $3.028B 20.78
Procaps Group, S.A (PROCF) Luxembourg $2.926B 0.00
Catalyst Pharmaceuticals (CPRX) United States $2.829B 9.03
Dyne Therapeutics (DYN) United States $2.689B 0.00
Soleno Therapeutics (SLNO) United States $2.543B 0.00
Ocular Therapeutix (OCUL) United States $2.384B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $2.007B 23.78
Guardian Pharmacy Services (GRDN) United States $1.926B 37.10
Avadel Pharmaceuticals (AVDL) Ireland $1.879B 0.00
Collegium Pharmaceutical (COLL) United States $1.466B 7.26
BioCryst Pharmaceuticals (BCRX) United States $1.453B 86.25
Ardelyx (ARDX) United States $1.417B 0.00
Harrow (HROW) United States $1.403B 86.11
Amylyx Pharmaceuticals (AMLX) United States $1.364B 0.00
Xeris Biopharma Holdings (XERS) United States $1.205B 0.00
Enliven Therapeutics (ELVN) United States $1.203B 0.00
Evotec AG (EVO) Germany $1.126B 0.00
Relay Therapeutics (RLAY) United States $1.118B 0.00
Nektar Therapeutics (NKTR) United States $1.097B 0.00
Oruka Therapeutics (ORKA) United States $1.096B 0.00
Xencor (XNCR) United States $0.999B 0.00
Cronos Group (CRON) Canada $0.950B 0.00
Theravance Biopharma (TBPH) United States $0.910B 38.19
Savara (SVRA) United States $0.867B 0.00
ARS Pharmaceuticals (SPRY) United States $0.831B 0.00
Organogenesis (ORGO) United States $0.788B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.724B 6.46
Elite Pharmaceuticals (ELTP) United States $0.719B 0.00
Esperion Therapeutics (ESPR) United States $0.708B 0.00
ProKidney (PROK) United States $0.671B 0.00
KalVista Pharmaceuticals (KALV) United States $0.662B 0.00
Lexeo Therapeutics (LXEO) United States $0.656B 0.00
Aquestive Therapeutics (AQST) United States $0.647B 0.00
Bioventus (BVS) United States $0.627B 12.83
4D Molecular Therapeutics (FDMT) United States $0.587B 0.00
Ironwood Pharmaceuticals (IRWD) United States $0.547B 12.96
Zevra Therapeutics (ZVRA) United States $0.520B 0.00
Akebia Therapeutics (AKBA) United States $0.467B 0.00
Siga Technologies (SIGA) United States $0.435B 5.96
Altimmune (ALT) United States $0.424B 0.00
Lyell Immunopharma (LYEL) United States $0.369B 0.00
Nature's Sunshine Products (NATR) United States $0.363B 21.60
Galectin Therapeutics (GALT) United States $0.357B 0.00
USANA Health Sciences (USNA) United States $0.354B 9.88
Aldeyra Therapeutics (ALDX) United States $0.302B 0.00
Pyxis Oncology (PYXS) United States $0.279B 0.00
Larimar Therapeutics (LRMR) United States $0.272B 0.00
Avalo Therapeutics (AVTX) United States $0.267B 0.00
Aclaris Therapeutics (ACRS) United States $0.251B 0.00
Achieve Life Sciences (ACHV) Canada $0.244B 0.00
OmniAb (OABI) United States $0.219B 0.00
AleAnna (ANNA) United States $0.217B 0.00
MediWound (MDWD) Israel $0.204B 0.00
Heron Therapeutics (HRTX) United States $0.204B 0.00
Protara Therapeutics (TARA) United States $0.203B 0.00
Journey Medical (DERM) United States $0.202B 0.00
Profound Medical (PROF) Canada $0.192B 0.00
Innate Pharma SA (IPHYF) France $0.168B 0.00
China SXT Pharmaceuticals (SXTC) China $0.151B 0.00
Cassava Sciences (SAVA) United States $0.142B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.142B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.136B 0.00
Relmada Therapeutics (RLMD) United States $0.129B 0.00
Incannex Healthcare (IXHL) Australia $0.124B 0.00
Inhibikase Therapeutics (IKT) United States $0.119B 0.00
Unicycive Therapeutics (UNCY) United States $0.115B 0.00
Avita Medical (RCEL) United States $0.114B 0.00
Gain Therapeutics (GANX) United States $0.108B 0.00
Context Therapeutics (CNTX) United States $0.106B 0.00
Surrozen (SRZN) United States $0.104B 0.00
Cardiol Therapeutics (CRDL) Canada $0.101B 0.00
Champions Oncology (CSBR) United States $0.095B 34.50
Prelude Therapeutics (PRLD) United States $0.095B 0.00
Karyopharm Therapeutics (KPTI) United States $0.094B 0.00
VAXART, INC (VXRT) United States $0.088B 0.00
Vivani Medical (VANI) United States $0.086B 0.00
Assertio Holdings (ASRT) United States $0.079B 0.00
Dominari Holdings (DOMH) United States $0.078B 0.00
PMV Pharmaceuticals (PMVP) United States $0.072B 0.00
Plus Therapeutics (PSTV) United States $0.072B 0.00
Nutriband (NTRB) United States $0.068B 0.00
Lite Strategy (LITS) United States $0.068B 0.00
Rafael Holdings (RFL) United States $0.065B 0.00
Acrivon Therapeutics (ACRV) United States $0.065B 0.00
Metagenomi (MGX) United States $0.064B 0.00
BioNxt Solutions (BNXTF) Canada $0.061B 0.00
Korro Bio (KRRO) United States $0.061B 0.00
PolyPid (PYPD) Israel $0.057B 0.00
Fractyl Health (GUTS) United States $0.056B 0.00
NRx Pharmaceuticals (NRXP) United States $0.051B 0.00
Wellgistics Health (WGRX) United States $0.049B 0.00
Talphera (TLPH) United States $0.049B 0.00
ElectroCore (ECOR) United States $0.046B 0.00
Jupiter Neurosciences (JUNS) United States $0.046B 0.00
Telomir Pharmaceuticals (TELO) United States $0.045B 0.00
Century Therapeutics (IPSC) United States $0.040B 0.00
Tempest Therapeutics (TPST) United States $0.039B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.038B 0.00
FibroGen (FGEN) United States $0.037B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.037B 0.00
Mural Oncology (MURA) Ireland $0.036B 0.00
Inotiv (NOTV) United States $0.036B 0.00
Klotho Neurosciences (KLTO) United States $0.033B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.031B 26.12
Liminatus Pharma (LIMN) United States $0.029B 0.00
Vyome Holdings (HIND) United States $0.028B 0.00
Scienture Holdings (SCNX) United States $0.027B 0.00
Iterum Therapeutics (ITRM) Ireland $0.027B 0.00
Cosmos Health (COSM) United States $0.025B 0.00
SCYNEXIS (SCYX) United States $0.025B 0.00
Enlivex Therapeutics (ENLV) Israel $0.024B 0.00
Natural Alternatives (NAII) United States $0.021B 0.00
TherapeuticsMD (TXMD) United States $0.019B 0.00
Vivos Therapeutics (VVOS) United States $0.018B 0.00
Mannatech (MTEX) United States $0.018B 0.00
Citius Pharmaceuticals (CTXR) United States $0.017B 0.00
Heatwurx (PCSA) United States $0.017B 0.00
CASI Pharmaceuticals (CASI) China $0.016B 0.00
Lipocine (LPCN) United States $0.016B 0.00
BioLineRx (BLRX) Israel $0.015B 0.00
Traws Pharma (TRAW) United States $0.013B 0.02
Mangoceuticals (MGRX) United States $0.013B 0.00
Ernexa Therapeutics (ERNA) United States $0.012B 0.00
Ainos (AIMD) United States $0.012B 0.00
VYNE Therapeutics (VYNE) United States $0.012B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.012B 0.00
BioVie (BIVI) United States $0.011B 0.00
ProPhase Labs (PRPH) United States $0.010B 0.00
Addex Therapeutics (ADXN) Switzerland $0.009B 0.00
Phio Pharmaceuticals (PHIO) United States $0.008B 0.00
Kiora Pharmaceuticals (KPRX) United States $0.008B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.008B 0.00
Aptorum Group (APM) United Kingdom $0.008B 0.00
Biomerica (BMRA) United States $0.007B 0.00
TransCode Therapeutics (RNAZ) United States $0.007B 0.00
Lyra Therapeutics (LYRA) United States $0.007B 0.00
Alaunos Therapeutics (TCRT) United States $0.007B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.006B 0.00
Nuvilex (PMCB) United States $0.005B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.005B 0.00
InMed Pharmaceuticals (INM) Canada $0.005B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.005B 0.00
Qualigen Therapeutics (QLGN) United States $0.004B 0.00
Xenetic Biosciences (XBIO) United States $0.004B 0.00
Jaguar Animal Health (JAGX) United States $0.004B 0.00
Redhill Biopharma (RDHL) Israel $0.004B 0.00
Indaptus Therapeutics (INDP) United States $0.003B 0.00
CDT Equity (CDT) United States $0.003B 0.00
XORTX Therapeutics (XRTX) Canada $0.003B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.002B 0.00
Universe Pharmaceuticals INC (UPC) China $0.002B 0.00
Clearmind Medicine (CMND) Canada $0.002B 0.00
PainReform (PRFX) Israel $0.002B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.002B 0.00
SciSparc (SPRC) Israel $0.001B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.001B 0.00
Aditxt (ADTX) United States $0.000B 0.00
Curanex Pharmaceuticals Inc (CURX) United States $0.000B 0.00
Emisphere Technologies (EMIS) United States $0.000B 0.00
Indivior (INDV) United States $0.000B 15.22
4D Pharma (LBPS) United Kingdom $0.000B 0.00
Minerva Neurosciences (NERV) United States $0.000B 0.00
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00
Silence Therapeutics (SLN) United Kingdom $0.000B 0.00